News

We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”…

PhinC Development is proud to sponsor and participate in the special event organized by the Groupe de Métabolisme et Pharmacocinétique (GMP) that will be held in Paris on 16th to 18th October 2019.

PhinC Development would like to thank you for being part of this special event dedicated to the PBPK and organised jointly with Club Phase 1.